• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

AtriCure Inc.

AtriCure treats first patient in Isolator Synergy clamp trial

June 7, 2022 By Sean Whooley

AtriCure (Nasdaq:ATRC) announced today that it treated the first patient in its HEAL-IST clinical trial in Belgium. Dr. Mark LaMeir and Dr. Carlo de Asmundis treated the first patient in the HEAL-IST trial evaluating the AtriCure Isolator Synergy clamp for treating drug-refractory patients diagnosed with inappropriate sinus tachycardia (IST) at University Hospital Brussels. “Symptomatic IST […]

Filed Under: Cardiovascular, Clinical Trials, Vascular Tagged With: atricure, AtriCure Inc.

AtriCure launches clamp for cardiac tissue ablation

April 12, 2022 By Sean Whooley

AtriCure (Nasdaq:ATRC) announced today that it launched the EnCompass Clamp as part of its Isolator Synergy ablation system. Mason, Ohio-based AtriCure received FDA 510(k) clearance for the EnCompass Clamp for the ablation of cardiac tissue during cardiac surgery to make concomitant surgical ablations more efficient. According to a news release, the platform includes parallel closure, […]

Filed Under: 510(k), Business/Financial News, Cardiac Implants, Cardiovascular, Food & Drug Administration (FDA), Radiosurgery/Radiation therapy, Regulatory/Compliance, Structural Heart Tagged With: atricure, AtriCure Inc.

These medtech companies care a lot about research

January 19, 2022 By Chris Newmarker

They’re making glaucoma-treating stents, tumor-treating fields, coin-sized CGMs and more. Discover the medtech companies that spend the most on research as a percentage of revenue. The list comes from our annual Big 100 report, which examines the world’s 100 largest medical device companies and ranks them by revenue. (Check out our full Big 100 report […]

Filed Under: Bioelectronic Medicine, Business/Financial News, Cardiovascular, Diabetes, Featured, Neuromodulation/Neurostimulation, News Well, Oncology, Optical/Ophthalmic, Research & Development Tagged With: AtriCure Inc., Big 100, Dexcom, Glaukos, Inspire Medical Systems Inc., NovoCure

AtriCure beats The Street in Q2 results

August 5, 2021 By Danielle Kirsh

AtriCure (NSDQ:ATRC) posted second-quarter results this week that beat the overall consensus on Wall Street. The Mason, Ohio-based company reported losses of -$16.3 million, or -36¢ per share, on sales of $71.4 million for the three months ended June 30 for a sales growth of 74.84% compared with Q2 2020. Adjusted to exclude one-time items, earnings […]

Filed Under: Cardiovascular, MassDevice Earnings Roundup, Wall Street Beat Tagged With: AtriCure Inc.

AtriCure AFib treatment device wins FDA approval

April 29, 2021 By Sean Whooley

AtriCure (NSDQ:ATRC) announced today that the FDA approved its EPi-Sense system for treating long-standing persistent atrial fibrillation (Afib). Mason, Ohio-based AtriCure’s EPi-Sense system demonstrated superiority in the Hybrid AF therapy arm compared to endocardial catheter ablation alone in the Converge clinical trial, according to a news release. AtriCure’s Hybrid AF therapy is a minimally invasive […]

Filed Under: Cardiovascular, Clinical Trials, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Structural Heart Tagged With: atricure, AtriCure Inc., FDA

AtriCure names Angie Wirick as chief financial officer

August 10, 2020 By Danielle Kirsh

AtriCure (NASDAQ:ATRC) recently announced that it has appointed Angie Wirick as chief financial officer, effective August 6. Wirick, who was VP of finance, replaces Andy Wade who is stepping down for personal reasons and will continue to serve in an advisory role through March 5, 2021. “On behalf of our team at AtriCure and our Board […]

Filed Under: Business/Financial News, Cardiovascular Tagged With: AtriCure Inc.

AtriCure to raise $100m from public offering

May 11, 2020 By Chris Newmarker

AtriCure (NASDAQ:ATRC) said today that it commenced a public offering to issue and sell roughly $100 million worth of its common stock. The Mason, Ohio–based company — maker of treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management — said it plans to grant the underwriters of the offering a 30-day option to […]

Filed Under: Business/Financial News, Cardiovascular, Funding Roundup, Wall Street Beat Tagged With: AtriCure Inc.

These 10 medtech companies care a lot about research

November 1, 2019 By Danielle Kirsh

These 10 medical device companies spent the largest portion of their budgets on research and development. Here’s a look at what they produced. Each year, Medical Design & Outsourcing compiles a list of the top 100 medical device companies across the globe and ranks the companies based on annual revenue for the most recent fiscal year. We […]

Filed Under: Business/Financial News Tagged With: AtriCure Inc., Big 100, Brainsway, conformis, Dexcom, Edwards Lifesciences, Glaukos, Inspire Medical Systems Inc., Insulet, Ra Medical, TransEnterix

AtriCure wins expanded indications for AtriClip LAA

August 27, 2019 By Brad Perriello

AtriCure (NSDQ:ATRC) said today that it won expanded 510(k) clearances from the FDA for its AtriClip left atrial appendage device. The new indications cover a change from occlusion of the LAA to exclusion and adding electrical isolation as a claim, Mason, Ohio-based AtriCure said. AtriClip excludes the LAA and causes its tissue to die from loss […]

Filed Under: Cardiac Implants, Cardiovascular, Featured, Food & Drug Administration (FDA), Mergers & Acquisitions, Regulatory/Compliance, Wall Street Beat Tagged With: AtriCure Inc.

AtriCure closes $300m SentreHeart buyout

August 14, 2019 By Brad Perriello

AtriCure (NSDQ:ATRC) said yesterday that it closed the $300 million buyout of SentreHeart and its Lariat left atrial appendage closure device. The offer included $40 million in up-front cash and stock, plus $140 million in clinical and regulatory milestones and $120 million in reimbursement milestones, all payable in cash and stock, Mason, Ohio-based AtriCure said when the […]

Filed Under: Cardiovascular, Featured, Mergers & Acquisitions, Wall Street Beat Tagged With: AtriCure Inc., SentreHeart

AtriCure offers $300m for SentreHeart

August 12, 2019 By Brad Perriello

AtriCure (NSDQ:ATRC) said today that it put up a $300 million offer for SentreHeart and its Lariat left atrial appendage closure device. Redwood City, Calif.-based SentreHeart has enrolled 535 patients in the Amaze trial comparing Lariat and pulmonary vein isolation with PVI alone in treating atrial fibrillation. Today AtriCure said it expects the study tor each […]

Filed Under: Cardiac Implants, Cardiovascular, Featured, Mergers & Acquisitions, Wall Street Beat Tagged With: AtriCure Inc., SentreHeart

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 11
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS